Mold-Tek Packaging Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹203Cr
- +14.7% YoY
- +6.3% QoQ
- Net profit
- ₹16Cr
- −11.1% YoY
- +14.3% QoQ
- Margin
- 19%
- −1 pp YoY
- +1 pp QoQ
Guidance rank: #86 of 100 in Industrial Products
See the sector's top 10 — free with your mobile number.
The short version
Pharma segment expected to see 2.3x to 3x growth in next financial year, targeting Rs. 30+ crores in FY26 and Rs. 50+ crores in FY27. The company expects at least a 15% volume growth in FY ‘26 with EBITDA per kg targeting between Rs. 41 and Rs. 42.
From Mold-Tek Packaging Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Pharma segment expected to see 2.3x to 3x growth in next financial year, targeting Rs. 30+ crores in FY26 and Rs. 50+ crores in FY27.
- Pharma volumes aimed at 3,000 tons per annum by end of FY26, with revenue potential of Rs. 90-100 crores.
- Paint segment growth in FY26 expected to reach double digits (~10%) driven by capacity expansions and increased IML adoption by Asian Paints.
- Food & FMCG segment targeting 15%-20% growth in FY26 due to enhanced printing capacity and new client additions.
- Overall company volume growth target for FY26 is around 15%.
- EBITDA per kg expected to improve, with internal targets around Rs. 41-42 per kg in FY26, driven by pharma and food/FMCG segments.
2 more points from Mold-Tek Packaging Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Mold-Tek Packaging Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- FY '26 CAPEX is guided between Rs. 70 to 80 crores, partly for pharma and printing expansion.
- Pharma segment is getting Rs. 20-25 crores for land acquisition and building completion at Sultanpur.
- Existing Sultanpur facility capacity being expanded from 1,500 tons to 3,000 tons per annum by March 2026.
- New land (~2.5 acres) acquired adjacent to Sultanpur for future pharma expansion beyond 3,000 tons capacity.
- Additional machines (injection molding, printing) being added; 5 new injection molding machines to arrive by June.
- Printing capacity increased by 70% with investments of over Rs. 25 crores in the previous financial year.
- ABG (Aditya Birla Group) capacity enhanced with Brownfield expansion, operating fully from March-April 2025.
- Strategic focus on pharma growth: expecting 2.3x to 3x pharma revenue growth next financial year; exploring export opportunities.
2 more points from Mold-Tek Packaging Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Industrial Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Mold-Tek Packaging Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Mold-Tek Packaging Ltd's call on order book
Create a free account to keep reading this call
Mold-Tek Packaging Ltd — Quarterly revenue & net profit
Mold-Tek Packaging Ltd Q4 FY25 results — key figures
| ₹ Cr | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 203 | 177 | +14.7% | 191 | +6.3% |
| Operating profit (EBITDA) | 38 | 36 | +5.6% | 34 | +11.8% |
| Operating margin | 19% | 20% | -1 pp | 18% | +1 pp |
| Profit before tax | 22 | 24 | -8.3% | 18 | +22.2% |
| Net profit (PAT) | 16 | 18 | -11.1% | 14 | +14.3% |
| EPS (₹) | 2.45 | 2.70 | -9.3% | 2.05 | +19.5% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹274 Cr, net profit ₹21 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Mold-Tek Packaging's management said in earlier quarters
Others in Industrial Products this season
- Graphite India (Q4 FY25)
666 Crores, down 7.5% year-on-year (YoY) from Rs. Key concall takeaways from Graphite India Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Welspun Specialty Solutions (Q4 FY25)
Q4 FY25 Revenue: INR 2,085 million, up 33% YoY from INR 1,564 million in Q4 FY24 (Page 12, Page 11) . Key concall takeaways from Welspun Specialty Solutions…
- Grindwell Norton (Q4 FY25)
Revenue from Operations for FY 2024-25 is ₹2812 crores, a 4.6% increase from ₹2687 crores in FY 2023-24. Key concall takeaways from Grindwell Norton Ltd's Q4…
- PTC Industries (Q4 FY25)
Q4 FY25 Total Income:** ₹133.8 Cr, up 74.9% YoY from ₹76.5 Cr in Q4 FY24 (Page 6, 5). Key concall takeaways from PTC Industries Ltd's Q4 FY25 earnings call…
Potential multibaggers · Q2 FY27
Potential multibaggers in Industrial Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Mold-Tek Packaging Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Mold-Tek Packaging Ltd Q4 FY25 results?
Pharma segment expected to see 2.3x to 3x growth in next financial year, targeting Rs. 30+ crores in FY26 and Rs. 50+ crores in FY27. The company expects at least a 15% volume growth in FY ‘26 with EBITDA per kg targeting between Rs. 41 and Rs. 42.
What is Mold-Tek Packaging Ltd share price analysis?
Mold-Tek Packaging Ltd currently shows a neutral. The stock trades at a P/E of 30.3 with a market cap of ₹2,307 Cr. Investors should review the full earnings analysis for detailed insights.
Is Mold-Tek Packaging Ltd planning capital expenditure?
FY '26 CAPEX is guided between Rs. 70 to 80 crores, partly for pharma and printing expansion.
Keep Mold-Tek Packaging Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
